Abstract:Objective:To explore the clinical characteristics of children with tyrosine hydroxylase deficiency (THD) in order to recognize this disease early as to optimize the treatment to improve the prognosis.Methods:A retrospective analysis was done on the clinical data of nine children with THD who were diagnosed at the Children′s Hospital of Fudan University from May 2018 to May 2020, including name, gender, age, age of onset, age of presentation, age of diagnosis, clinical manifestations, head imaging, tyrosine hydroxylase gene mutation, treatment, follow-up, and other results, which were classified according to Willemsen′s method, and the clinical characteristics were summarized and a literature review was carried out.Results:There were five males and four females with the age at onset ranged from newborn to two years and six months (median three months). The duration of diagnosis ranged from four months to five years and seven months (median nine months). The presenting symptom was motor retardation in seven cases. Clinical symptoms included hypokinesia in eight cases, limb dystonia in five cases, truncal hypotonia in four cases, dysphagia/dysarthria in four cases, oculogyric crises in four cases, tremor in three cases, rigidity in three cases, mask faces in three cases, bilateral ptosis in two cases, hypersalivation/sweating in two cases, diurnal fluctuation in two cases, myoclonic jerks in one case, and status dystonicus in one case. Cranial magnetic resonance imaging was normal in seven cases and non-specific in two cases (backward myelination in one case and bilateral ventricle enlargement and decreased white matter in another one). Eight tyrosine hydroxylase gene variants were found, including four missense variants, two frameshift variants, one shear variants and one nonsense variant, as well as three novel variants [c.1505_1518dup (p.R507Afs *23), c.1128_1138del (p.Q377Gfs *12), c.1058A>G(p.H353R)]. All patients were treated with levodopa and benserazide hydrochloride tables. The initial and maintenance doses of type A were 1.7-8.3 mg·kg -1·d -1 and 4.5-20.0 mg·kg -1·d -1, respectively. The initial and maintenance doses of type B were 1.7-12.5 mg·kg -1·d -1 and 4.6-12.0 mg·kg -1·d -1, respectively. In type A, four patients had dyskinesis which was relieved by decreasing the dose or maintaining the same dose of levodopa. One case of type B had dyskinesis which was self-resolving. Conclusions:Although the clinical manifestations of this disease are varied, the initial symptoms in children with onset within the first year of life are mostly hypokinesia, truncal hypotonia, and dystonia in limbs. It is recommended that children with THD, regardless of clinical type, should start at the minimum dose for easy segmentation in the range of 1.0-5.0 mg·kg -1·d -1, and the maintenance dose can be adjusted according to the individual response of the child. The incidence of dyskinesia of this disease is not low, but most can be treated by decreasing the initial dose and delaying the dosage rate.

R233H Mutation in Patients with Tyrosine Hydroxylase Deficiency and Corresponding Phenotypes: a Study of Four Cases and Literature Review.

A Novel Tyrosine Hydroxylase Variant in a Group of Chinese Patients with Dopa-Responsive Dystonia.

The mitochondrial tRNAThr A15951G mutation may influence the phenotypic expression of the LHON-associated ND4 G11778A mutation in a Chinese family

[Tyrosine Hydroxylase Deficiency: a Case of Autosomal Recessive Dopa-Responsive Dystonia].

Rare hypertension as a result of 17alpha-hydroxylase deficiency.

[Thyrotropin Receptor Gene Inactivating Mutation in Chinese Children with Congenital Hypothyroidism].

The Novel A4435g Mutation In The Mitochondrial Trnamet May Modulate The Phenotypic Expression Of The Lhon-Associated Nd4 G11778a Mutation

Thyrotropin Receptor and Thyroid Transcription Factor-1 Genes Variant in Chinese Children with Congenital Hypothyroidism.

Clinical and genetic analysis of tetrahydrobiopterin-responsive phenylalanine hydroxylase deficiency

[Clinical and genetic analysis of tyrosine hydroxylase deficiency of six cases].

GTP Cyclohydrolase I and Tyrosine Hydroxylase Gene Mutations in Familial and Sporadic Dopa-Responsive Dystonia Patients.

Clinical and genetic study on 5 children with dopa-responsive dystonia due to tyrosine hydroxylase deficiency

Identification and Functional Characterization of a Novel Homozygous Intronic Variant in the Fumarylacetoacetate Hydrolase Gene in a Chinese Patient with Tyrosinemia Type 1.

Mutation analysis of FAH gene in patients with tyrosinemia type 1

Screening for Hereditary Tyrosinemia and Genotype Analysis in Newborns

Clinical analysis of nine infants with tyrosine hydroxylase deficiency

Study of GCH1 and TH genes in Chinese patients with Parkinson's disease.

Novel HPD Mutation P.a244v Compound with P.t219m Causing Tyrosinemia Type III in a Chinese Girl and Review of the Genotype–phenotype Spectrum

Two Novel Mutations of the GTP Cyclohydrolase 1 Gene and Genotype–phenotype Correlation in Chinese Dopa-responsive Dystonia Patients

Phenotype-genotype Correlation in Eight Chinese 17Alpha-Hydroxylase/17,20 Lyase-Deficiency Patients with Five Novel Mutations of CYP17A1 Gene.

Tyrosine hydroxylase variants influence protein expression, cellular localization, stability, enzymatic activity and the physical interaction between tyrosine hydroxylase and GTP cyclohydrolase 1